Stock Price & Analysis

Based on current trends and analysis, AME stock shows strength with positive market movement and improving sentiment. It is currently a hold as it nears all-time highs but maintains positive analyst sentiment.

The price prediction for AME stock in 2025 is $210. This forecast is based on the Strong Buy rating from Truist Securities with a price target of $222 and the Hold rating from Baird with a target of $197, suggesting potential upside driven by improving organic growth and strong cash flow performance.

The S1 support level for AME Stock is $169.08 ,The R1 resistant level for AME Stock is $179.31.

As of the end of day on 2025-04-01, the price of AME Stock was $171.89.

The target price for AME Stock according to analyst rating is 199.17, with the highest price target at 216.00 and the lowest at 158.00. Analysts have a Moderate Buy rating on AME Stock overall.

The market cap of AME is $39.7B.

AME appears overvalued based on several key metrics and market indicators. Here's a concise analysis:

1. High Valuation Metrics: AME's PE ratio of 30.41 and EV/EBITDA of 20.07 suggest the stock is trading at a premium. These metrics are significantly higher than industry averages, indicating potential overvaluation.

2. Underperformance: AME's stock has dropped 10.6% from its all-time high and underperformed the Industrial Select Sector SPDR Fund over the past three months and year, signaling weak market confidence.

3. Mixed Financial Results: While AME reported strong cash flows and EPS that beat estimates, its Q4 results showed a 1.7% decline in one segment's sales, raising concerns about growth consistency.

4. Insider Activity: A director sold 1,320 shares, and institutional investors showed mixed sentiment, with more sellers than buyers in the last quarter, indicating cautious stakeholder sentiment.

5. Analyst Outlook: Despite a "Moderate Buy" rating, the mean price target suggests only a 15.4% upside, which may not justify the current valuation given the risks.

Conclusion: AME's high valuation, underperformance, mixed financials, and insider activity suggest the stock is overvalued. Investors should exercise caution and consider waiting for a price correction or improved fundamentals before investing.

AMETEK, Inc. is a global provider of industrial technology solutions serving a diverse set of niche markets. The Company’s segments include Electronic Instruments (EIG) and Electromechanical (EMG). The EIG segment manufactures advanced instruments for the process, power and industrial, and aerospace markets. It provides process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries. The EIG segment also provides instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets. The EMG segment designs and manufactures engineered medical components and devices, automation solutions, thermal management systems, specialty metals and electrical interconnects. The Company’s EMG segment makes precision motion control products for data storage, medical devices, business equipment, automation, and other applications.

AME stock is predicted to reach $250 by 2030, driven by strong financial performance and analyst optimism. The stock is expected to trade in a range of $220 to $280, supported by its solid cash flows and growth prospects.

AME has a total of 21500 employees.